the cnio integrates resources devoted to basic research as well as research directly applied to diagnose, pharmaceutics and clinical practice. it consists of 49 research groups distributed in three basic research programs (molecular oncology, structural biology and biocomputation, and cancer cellular biology) and two applied research programs (human cancer genetics and clinical research). these programs are supported by an area of innovation which includes a biotechnology program, offering advanced technological support to research programs; an experimental therapy program, focused in pharmaceutical development, and an office for technological transfer and evaluation.